shizu
hayashi
jame
c
hogg
adenoviru
particularli
protein
investig
pathogenesi
chronic
obstruct
pulmonari
diseas
copd
high
level
dna
found
lung
copd
patient
express
increas
diseas
sever
lung
epitheli
cell
increas
intercellular
adhes
express
well
nuclear
factorkb
activ
respons
inflammatori
stimuli
addit
regul
mediat
promot
emphysema
upregul
transform
growth
express
bronchiolar
epitheli
cell
transform
lung
epitheli
cell
express
mesenchym
marker
result
support
addit
role
airway
remodel
process
report
copd
first
identif
distinct
viral
agent
present
today
adenovirus
recogn
etiolog
agent
respiratori
gastrointestin
tract
eye
kidney
recent
organ
consequ
solid
organ
bone
marrow
transplant
associ
immunosuppress
review
focus
virus
respiratori
pathogen
particularli
group
c
adenovirus
signific
infect
agent
lower
respiratori
tract
wherea
adenoviru
infect
mild
selflimit
consider
morbid
even
death
occur
pediatr
popul
militari
recruit
immunocompromis
individu
adenoviru
persist
latenc
support
possibl
consequ
immunosuppress
otherwis
quiescent
viru
either
recipi
host
transplant
donor
organ
reactiv
caus
seriou
diseas
pauciti
treatment
option
control
infect
emphas
urgent
need
wellcontrol
clinic
trial
therapeut
modal
current
develop
besid
diseas
caus
infect
viru
latent
infect
adenovir
protein
express
absenc
replic
viru
postul
play
role
pathogenesi
chronic
obstruct
pulmonari
diseas
copd
cigarett
smoke
account
less
risk
develop
diseas
review
review
summar
evid
support
hypothesi
lung
tissu
copd
patient
anim
model
lung
epitheli
cell
mechan
could
enhanc
inflammatori
respons
lung
patient
promot
emphysema
studi
recent
advanc
understand
mechan
present
well
result
support
role
adenoviru
airway
remodel
observ
copd
adenovirus
nonenvelop
icosahedr
doublestrand
dna
virus
infect
wide
rang
vertebr
human
adenovirus
compris
serotyp
classifi
six
group
f
accord
sequenc
homolog
oncogen
inject
rat
group
prefer
site
infect
mainli
caus
mild
diseas
immunocompet
individu
site
tabl
common
human
adenovirus
belong
group
c
predominantli
infect
upper
respiratori
tract
group
along
group
b
e
infect
lower
respiratori
tract
caus
clinic
symptom
rang
mild
pharyng
acut
respiratori
diseas
icosahedr
capsid
adenoviru
compos
hexon
penton
protein
fiber
protein
protrud
vertic
form
penton
base
knob
domain
serv
ligand
receptor
host
cell
knob
domain
group
c
e
f
adenovirus
attach
coxsacki
b
viru
adenoviru
receptor
host
cell
surfac
wherea
group
b
virus
except
serotyp
attach
bind
facilit
interact
penton
base
member
integrin
famili
predominantli
v
b
requir
intern
viru
detail
adenoviru
intern
includ
fiber
shed
endocytosi
releas
endosom
loss
penton
base
review
viral
capsid
direct
microtubul
nuclear
pore
nuclear
import
hexon
result
releas
viral
dna
nucleu
transcript
replic
packag
nucleu
product
first
viral
gene
express
activ
express
viral
gene
requir
viral
replic
bind
directli
promot
gene
interact
cellular
transcript
factor
regulatori
protein
necessari
transcript
gene
capac
bind
host
transcript
regul
thu
regul
viral
gene
also
gene
host
cell
relev
role
pathogenesi
copd
see
persist
adenoviru
infect
shed
replicationcompet
viru
latent
infect
report
particularli
lymphocyt
viral
dna
absenc
infecti
viru
detect
review
test
whether
gene
region
also
express
earli
viral
lifecycl
assist
subvert
host
immun
respons
viru
affect
persist
possibl
mechan
investig
adenoviru
infect
occur
frequent
document
presenc
antibodi
one
adenoviru
serotyp
approxim
infant
nearli
adult
face
infect
diseas
immunocompet
individu
uncommon
rare
fatal
owe
potent
innat
adapt
immun
respons
howev
suscept
minor
particularli
pediatr
age
group
militari
recruit
immunosuppress
either
transplant
cancer
hiv
infect
diseas
common
tabl
figur
children
younger
five
year
age
vulner
probabl
primari
infect
adenoviru
caus
acut
respiratori
diseas
serotyp
commonli
found
group
c
group
b
adenoviru
account
pneumonia
popul
serotyp
isol
lung
includ
situ
hybrid
show
alveolar
bronchiolar
epitheli
cell
infect
adenoviru
pneumonia
figur
less
common
respiratori
consequ
adenoviru
infect
report
age
group
includ
bronchiol
postinfecti
bronchiol
obliteran
combin
preced
measl
infect
bronchiectasi
adenoviru
infect
report
militari
recruit
soon
discoveri
viru
fatigu
stress
crowd
live
condit
contribut
spread
adenoviru
infect
associ
morbid
mortal
immunocompromis
patient
grow
concern
particularli
increas
number
individu
undergo
solid
organ
bone
marrow
transplant
well
aid
malign
review
copd
defin
irrevers
airflow
limit
measur
volum
air
forcibl
expir
lung
one
second
ratio
forc
vital
capac
key
determin
limit
airflow
increas
resist
small
conduct
airway
less
mm
diamet
emphysemat
destruct
lung
elast
recoil
forc
avail
drive
expiratori
flow
copd
current
fourth
lead
caus
death
world
global
burden
diseas
url
http
wwwwhoint
pdf
increas
preval
mortal
predict
major
risk
factor
inhal
toxic
particl
gase
primarili
tobacco
smoke
respiratori
infect
earli
childhood
also
associ
reduc
lung
function
increas
respiratori
problem
later
life
could
lead
copd
potenti
childhood
respiratori
infect
risk
factor
copd
led
investig
adenovirus
owe
abil
commonli
produc
respiratori
infect
earli
childhood
unlik
common
childhood
respiratori
virus
rhinoviru
respiratori
syncyti
viru
parainfluenza
virus
influenza
coronaviru
rna
virus
adenoviru
doublestrand
dna
genom
confer
potenti
persist
nuclei
infect
cell
even
possibl
integr
chromosom
host
cell
notion
support
persist
latent
infect
report
furthermor
group
c
adenovirus
chosen
target
studi
serotyp
larg
ubiquit
children
besid
predomin
group
upper
respiratori
tract
infect
tabl
associ
pneumonia
infant
tabl
evid
also
infect
lower
respiratori
tract
studi
show
lung
copd
patient
asymptomat
viral
infect
harbour
group
c
adenoviru
dna
control
similar
histori
smoke
addit
show
protein
express
alveolar
bronchiolar
epitheli
cell
lung
protein
express
well
express
inflammatori
marker
intercellular
adhes
molecul
icam
number
inflammatori
cell
increas
diseas
sever
patient
role
adenoviru
infect
copd
support
studi
guineapig
initi
acut
infect
adenoviru
subsid
viral
replic
ceas
dna
protein
continu
detect
alveolar
airway
epitheli
cell
bronchiol
persist
shortterm
chronic
exposur
cigarett
smoke
time
increas
number
inflammatori
cell
caus
emphysemalik
chang
respect
compar
uninfect
anim
increas
inflamm
copd
discuss
capac
regul
gene
transcript
host
cell
determin
whether
basi
relationship
increas
lung
inflamm
copd
cell
model
reproduc
permiss
alveolar
epitheli
cell
primari
bronchiolar
epitheli
cell
express
adenoviru
develop
respect
celltyp
presenc
increas
interleukin
il
express
respons
lipopolysaccharid
lp
stimul
inflammatori
mediat
increas
accompani
increas
bind
activ
transcript
factor
nuclear
factorkb
nfkb
bind
promot
gene
affect
promot
gene
support
evid
increas
promoterdriven
report
gene
express
presenc
result
suggest
regul
express
specif
mediat
respons
lp
common
mechan
moreov
mediat
promot
increas
number
neutrophil
lung
copd
patient
review
serv
potent
neutrophil
chemoattract
ligand
adhes
receptor
neutrophil
recent
sitedirect
mutagenesi
studi
show
two
nfkb
bind
site
promot
one
proxim
transcript
start
site
essenti
increas
express
present
e
ogawa
et
al
abstract
j
respir
crit
care
med
result
chromatin
immunoprecipit
assay
design
investig
whether
interact
protein
transcript
complex
assembl
site
promot
transcript
gene
bronchiolar
epitheli
cell
stimul
lp
presenc
increas
bind
nfkb
coactiv
rna
polymeras
ii
promot
also
present
site
k
morimoto
et
al
abstract
american
thorac
societi
intern
confer
may
express
gene
also
increas
respons
stimul
environment
particul
matter
mm
pm
increas
gene
express
associ
activ
nfkb
taken
togeth
result
suggest
lung
epitheli
cell
adenoviru
regul
express
mediat
relev
pathogenesi
copd
interact
transcript
regul
promot
gene
regul
respons
inflammatori
stimuli
ie
bacteria
environment
pollut
could
play
role
emphysemat
destruct
lung
copd
addit
modul
inflammatori
mediat
express
lung
epitheli
cell
adenoviru
upregul
express
transform
growth
connect
tissu
growth
factor
two
factor
import
extracellular
matrix
deposit
result
suggest
also
promot
process
peripher
airway
remodel
occur
copd
studi
use
guineapig
cell
demonstr
transform
peripher
lung
epitheli
cell
cell
mesenchym
phenotyp
myofibroblast
activ
tissu
repair
therebi
support
role
airway
remodel
review
emphas
signific
adenoviru
respiratori
pathogen
even
present
day
although
molecular
mechan
maintain
persist
latenc
elucid
viral
reservoir
remain
major
sourc
diseasecaus
agent
immunosuppress
individu
promis
treatment
option
antivir
drug
cidofovir
lipid
ester
limit
impact
newli
establish
infect
develop
latent
infect
could
also
sourc
adenoviru
lung
copd
patient
figur
although
integr
viral
dna
need
investig
therapi
latent
adenoviru
infect
copd
yet
develop
although
exacerb
copd
treat
success
glucocorticoid
therapi
prevent
continu
chronic
declin
lung
function
diseas
furthermor
result
guineapig
model
show
allerg
lung
inflamm
steroid
resist
presenc
latent
adenoviru
infect
whether
adenoviru
confer
similar
resist
inflamm
caus
bacteri
infect
studi
howev
unravel
augment
express
inflammatori
growthpromot
mediat
lung
cell
could
provid
insight
new
treatment
copd
recent
adenoviru
detect
pcr
plasma
adult
lung
transplant
recipi
median
time
detect
day
posttranspl
low
mean
viral
load
copiesml
plasma
patient
either
asymptomat
selflimit
febril
syndrom
despit
chang
immunosuppress
specif
antivir
therapi
author
note
contrast
previou
find
adenovir
pneumon
lung
transplant
patient
isol
episod
lowlevel
viremia
report
selflimit
trigger
acut
reject
declin
pulmonari
function
recent
highthroughput
technolog
appli
identifi
serotyp
adenoviru
swab
sampl
oropharynx
domin
hand
militari
recruit
well
surfac
air
environ
first
four
week
train
triangulationidentif
genet
evalu
risk
tiger
use
broad
pcr
prime
combin
determin
base
composit
amplicon
electrospray
ioniz
timeofflight
mass
spectrometri
identifi
pathogen
first
report
applic
technolog
serotyp
viru
studi
found
although
initi
neg
antibodi
either
adenoviru
percentag
recruit
posit
adenoviru
increas
enrol
end
studi
furthermor
identifi
febril
respiratori
ill
posit
adenoviru
surfac
air
sampl
posit
ison
mg
adenoviru
infect
transplant
recipi
clin
infect
di
ison
review
viral
epidemiolog
transplant
recipi
show
adenoviru
diseas
stem
cell
transplant
popul
rang
depend
upon
variabl
discuss
current
review
author
report
clinic
present
adenovir
diseas
popul
improv
seen
follow
applic
quantit
realtim
pcr
diagnosi
monitor
diseas
also
describ
studi
determin
whether
detect
viru
pcr
blood
sampl
effect
screen
identifi
asymptomat
patient
manag
option
section
updat
therapi
option
diseas
given
pauwel
ra
buist
p
jenkin
cr
hurd
ss
global
strategi
diagnosi
manag
prevent
chronic
obstruct
pulmonari
diseas
nation
heart
lung
blood
institut
world
health
organ
global
initi
chronic
obstruct
lung
diseas
gold
execut
summari
respir
care
